|
Market Closed -
Nasdaq
07:00:00 30/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 77.84 USD | +1.61% |
|
+21.99% | +31.82% |
| 27/10 | Tempus AI Receives EU Certification for xR RNA Sequencing | MT |
| 24/10 | Tempus AI, Inc. Enters Into Multi-Year Agreement With Bristol Myers Squibb To License Multimodal Oncology Data | CI |
Company Valuation: Tempus AI, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 5,315 | 10,505 | 14,038 | - | - |
| Change | - | 97.64% | 33.62% | - | - |
| Enterprise Value (EV) 1 | 5,302 | 10,990 | 14,733 | 14,626 | 14,403 |
| Change | - | 107.29% | 34.06% | -0.73% | -1.52% |
| P/E | -5.42x | -41.9x | -55.8x | -57.1x | -107x |
| PBR | 94.1x | 20.8x | 27.9x | 23.6x | 17.9x |
| PEG | - | 0.5x | 50.43x | 24.98x | 2.3x |
| Capitalization / Revenue | 7.67x | 8.26x | 8.8x | 7.13x | 5.92x |
| EV / Revenue | 7.65x | 8.64x | 9.24x | 7.43x | 6.08x |
| EV / EBITDA | -50.6x | -1,488x | 226x | 100x | 54x |
| EV / EBIT | -37.3x | -233x | -1,308x | 391x | 88x |
| EV / FCF | -25.1x | -46x | 181x | 293x | 116x |
| FCF Yield | -3.98% | -2.18% | 0.55% | 0.34% | 0.86% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -6.23 | -1.41 | -1.394 | -1.363 | -0.7287 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 693.4 | 1,272 | 1,595 | 1,968 | 2,370 |
| EBITDA 1 | -104.7 | -7.385 | 65.1 | 145.6 | 266.8 |
| EBIT 1 | -142 | -47.19 | -11.27 | 37.4 | 163.7 |
| Net income 1 | -746.3 | -245 | -246.1 | -247.5 | -135 |
| Net Debt 1 | -13.71 | 484.5 | 695.6 | 587.9 | 365 |
| Reference price 2 | 33.76 | 59.05 | 77.84 | 77.84 | 77.84 |
| Nbr of stocks (in thousands) | 157,446 | 177,907 | 180,435 | - | - |
| Announcement Date | 24/2/25 | 24/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -54.94x | 9.1x | 223.01x | -.--% | 13.82B | |
| 16.92x | 6.39x | 12.26x | 1.77% | 64.14B | |
| 30.57x | 8.11x | 26.59x | 0.05% | 55.53B | |
| 36.68x | 6.52x | 19.45x | 0.88% | 53.03B | |
| 35.39x | 3.41x | 14.74x | -.--% | 45.99B | |
| 49.25x | 5.68x | 31.09x | -.--% | 42.45B | |
| -19.59x | 189.6x | -20.86x | -.--% | 40.45B | |
| 31.7x | 8.06x | 20.96x | 0.41% | 32.25B | |
| 47.12x | 8.37x | 28.08x | -.--% | 34.47B | |
| 27.96x | 5.9x | 15.29x | -.--% | 24.23B | |
| Average | 20.10x | 25.11x | 37.06x | 0.31% | 40.64B | |
| Weighted average by Cap. | 25.14x | 24.83x | 23.49x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- TEM Stock
- Valuation Tempus AI, Inc.
Select your edition
All financial news and data tailored to specific country editions
